Endovia Health Sciences Announces U.S. Drug Enforcement Administration’s Decision To Transfer Marijuana From Schedule I To Schedule II Of Controlled Substances Act; Co. Plans To File Pre-Submission Conference With FDA For CannEpil
Endovia Health Sciences, Inc. (NYSE:EDVA) ("Endovia" or the "Company"), an emerging cannabinoid-based health sciences company, today welcomed recent developments in the federal marijuana rescheduling
The U.S. government moved marijuana from the strictest rules (Schedule I) to less strict rules (Schedule II), which means doctors might be able to study and use it as medicine more easily. Endovia is a company working on a marijuana-based medicine, so this rule change could help them move forward with their product, but it's still very early.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.